0.72, 0.65-0.79, p<0.001) rates associated with PVADs when compared to IABP.
METHODS This is a single center study evaluating the use of Impella in high-risk patients undergoing PCI. Impella use was classified as 'elective' in patients who were identified to be high-risk or in shock prior to the procedure (Group 1, N¼ 129). Patients who received an Impella as a result of an acute hemodynamic compromise or procedural complication were classified as 'emergent' (Group 2, N¼ 57). The primary endpoint was a composite MACE of in hospital mortality; vascular complications and BARC defined bleeding.
RESULTS Between 2010 and 2014, 187 high-risk patients underwent Impella placement. The baseline demographics of both groups were similar (Fig 1) . The mean age was 67.5 years (p¼ns). The mean ejection fraction was 28.3% (p¼ns). Elective Impella use (group 1) was associated with more complete revascularization (2.3 vs 1.3 stents, p<0.001), successful weaning and explant of Impella at end of procedure (79% vs 10%, p<0.001) and successful hemostasis with perclose in preclose fashion (81% vs 8%, p<0.001). The MACE rate in Group 1 was 24% v/s 67% in Group 2 (p<0.001) ( Table 1) . The drivers of this difference in MACE were in-hospital mortality (9% v/s 49%; p<0.001) and need for more blood transfusions in the emergent group (1.3% v/s 2.9;p¼0.009). In multivariate analysis, independent predictors of in hospital MACE events were emergent Impella placement (OR 6.14, p<0.001), baseline ejection fraction and removal of Impella at the end of the procedure (Fig 1) . METHODS We analyzed 61 consecutive patients with severe cardiopulmonary failure and complicating cardiogenic shock who were assisted by an emergent bypass system (EBS Ò Terumo, Tokyo, Japan) between January 2012 and May 2015. The primary outcome was the success rate of weaning from EBS. The secondary outcome was inhospital mortality.
RESULTS
The mean duration of PCPS was 77.6 hours and that of cardiopulmonary resuscitation (CPR) was 32 (52.5%). The rate of weaning was 23 (37.7%) and the rate of weaning from cardiac group was higher than non-cardiac group (51.2% vs. 10.0%, p¼0.002). In-hospital mortality occurred for 45 patients (63.4% vs. 95.0%, p¼0.012). 
